7.98
Immix Biopharma Inc (IMMX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Operating Expenses |
15.30%
12.46
|
10.80 | 10.89 | 7.6625 | 6.7177 |
| Operating Income/Loss |
15.30%
-12.46
|
-10.80 | -10.89 | -7.6625 | -6.7177 |
| Nonoperating Income/Loss |
27.40%
0.9137
|
0.7172 | 0.2167 | 0.0845 | 0.1041 |
| Income/Loss From Continuing Operations Before Tax |
14.43%
-11.54
|
-10.09 | -10.68 | -7.578 | -6.6136 |
| Income Tax Expense/Benefit |
0.0143
|
- | 0.0113 | 0.00772 | 0.00891 |
| Net Income/Loss |
14.43%
-11.56
|
-10.10 | -10.69 | -7.5857 | -6.6226 |
| Basic Average Shares |
15.17%
63.77
|
55.37 | - | 31.93 | 29.98 |
| Diluted Average Shares |
15.17%
63.77
|
55.37 | - | 31.93 | 29.98 |
| Basic Earnings Per Share |
0.00%
-0.18
|
-0.18 | - | -0.24 | -0.22 |
| Diluted Earnings Per Share |
0.00%
-0.18
|
-0.18 | - | -0.24 | -0.22 |
大文字化:
|
ボリューム (24 時間):